Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19228746 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer
Condition: Neoplasms, Breast
Intervention: Drug: lapatinib

Study has passed its completion date and status has not been verified in more than two years.